Clinical Review Fortnightly review: Management of patients with sickle cell disease BMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7109.656 (Published 13 September 1997) Cite this as: BMJ 1997;315:656 Article Related content Metrics Responses Peer review Related articles No related articles found. See more Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) BMJ October 22, 2020, 371 m3939; DOI: https://doi.org/10.1136/bmj.m3939 Emerging immunotherapies in multiple myeloma BMJ September 21, 2020, 370 m3176; DOI: https://doi.org/10.1136/bmj.m3176 Convalescent plasma for covid-19 BMJ September 15, 2020, 370 m3516; DOI: https://doi.org/10.1136/bmj.m3516 Personal use of permanent hair dyes and cancer risk and mortality in US women: prospective cohort study BMJ September 02, 2020, 370 m2942; DOI: https://doi.org/10.1136/bmj.m2942 Covid-19: US approves emergency use of convalescent plasma despite warnings over lack of evidence BMJ August 25, 2020, 370 m3327; DOI: https://doi.org/10.1136/bmj.m3327 Cited by... Analysis of Hippocampal Subfields in Sickle Cell Disease Using Ultrahigh Field MRIAbstract Fulltext PDF Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East LondonAbstract Fulltext PDF Acute complications of sickle cell disease in childrenAbstract Fulltext PDF Management of sickle cell diseaseAbstract Fulltext PDF Fast track admission for children with sickle cell crisesAbstract Fulltext PDF